Skip to content

Multiple Myeloma in Dogs: Plasma Cell Cancer Diagnosis and Treatment

Multiple Myeloma in Dogs: Plasma Cell Cancer Diagnosis and T

Last updated: May 16, 2026

What Multiple Myeloma Actually Is

Multiple myeloma in dogs is a cancer of plasma cells — the antibody-producing white blood cells of the immune system. In a healthy dog, plasma cells live in bone marrow and lymphoid tissue and produce a diverse repertoire of antibodies as needed. In multiple myeloma, a single plasma cell line transforms into a malignant clone, multiplies in the bone marrow, and produces enormous quantities of a single, useless antibody (called a monoclonal protein, or M-protein). The expanding clone crowds out normal bone marrow function, the M-protein damages organs, and lytic bone lesions develop where colonies of malignant plasma cells erode through the bone matrix.

It is an uncommon but well-characterized cancer in older dogs, with a typical age at diagnosis in the senior years and slight over-representation of certain large breeds. Multiple myeloma differs from the more common lymphoma in dogs in that lymphoma is a cancer of lymphocytes (different white-cell lineage) and tends to enlarge lymph nodes, while myeloma is plasma-cell-derived and primarily affects bone marrow and organ function via the abnormal protein. Both fall under the broader umbrella of cancer in dogs.

The Diagnostic Tetrad

The veterinary diagnostic criteria for multiple myeloma require any two of four classic findings — and dogs who meet three or all four are unambiguously myeloma. The four criteria are:

  • Monoclonal gammopathy on serum protein electrophoresis — a tall, narrow spike in the gamma-globulin region of the protein gel, indicating a single immunoglobulin clone is being mass-produced. Polyclonal gammopathy (broad-based elevation) is not myeloma; the spike pattern is what matters.
  • Bence Jones proteinuria — light-chain immunoglobulin fragments in the urine, detected by urine protein electrophoresis. Standard urine dipsticks usually miss this; specific testing is required.
  • Lytic bone lesions on radiographs — punched-out areas where myeloma colonies have eroded bone, classically in the spine, pelvis, ribs, skull, and long bones.
  • Greater than 5 to 20% plasma cells on bone marrow aspirate — abnormal plasma cell numbers on bone marrow cytology, often with atypical (malignant-appearing) features.

Most dogs ultimately have all four findings or three of four. The serum spike is usually the first finding that triggers the workup; bone marrow biopsy and radiographic skeletal survey complete the diagnosis.

How Multiple Myeloma Looks at Home

Owners typically describe a slow-developing constellation of nonspecific signs:

  • Lethargy and reduced activity
  • Reluctance to jump or climb stairs (early bone-pain or pathologic fracture risk)
  • Increased thirst and urination (high blood calcium and M-protein effects on kidneys)
  • Weight loss
  • Recurrent infections (functional immunodeficiency from suppression of normal antibody production)
  • Pale gums (anemia from marrow crowding)
  • Bleeding tendencies (M-protein interfering with platelet function or with coagulation factors)
  • Sudden lameness or back pain from a pathologic fracture through a lytic lesion
  • Seizures, vision changes, or other neurologic signs in advanced cases (high blood viscosity from massive M-protein levels — hyperviscosity syndrome)

The combination of an older dog with vague illness, drinking more water, and an elevated total protein on routine bloodwork frequently triggers the targeted workup that uncovers myeloma. Many dogs are also discovered through an incidental finding on senior wellness bloodwork.

The Diagnostic Workup

The standard workup builds the diagnostic tetrad and assesses complications:

  • CBC, chemistry panel, urinalysis — establishes baseline organ function; total protein elevation, normal albumin, and high globulin are characteristic; calcium is often elevated; urine protein-to-creatinine ratio is often elevated.
  • Serum protein electrophoresis — confirms monoclonal gammopathy and quantifies the spike.
  • Urine protein electrophoresis — looks for Bence Jones proteinuria (light chains).
  • Skeletal survey radiographs — evaluates spine, pelvis, ribs, skull, and long bones for lytic lesions.
  • Bone marrow aspirate and biopsy — quantifies plasma cell percentage and cytologic features.
  • Abdominal ultrasound and chest radiographs — assess organ involvement, look for splenomegaly or hepatomegaly, screen for complicating disease.
  • Coagulation panel — assesses bleeding risk; some myeloma dogs have abnormalities of clotting from M-protein interference.
  • Fundoscopy — eye exam looks for retinal hemorrhages and detachment from hyperviscosity.

This is an internal-medicine and oncology-level workup. Most cases are best handled by an ACVIM-Internal Medicine or ACVIM-Oncology specialist from the start.

Hyperviscosity Syndrome

Hyperviscosity syndrome is a complication of high circulating M-protein in which the blood becomes literally thicker and flows poorly through small vessels. Signs include retinal hemorrhages and visual changes, neurologic signs (seizures, behavior changes, weakness), bleeding tendencies, and signs of poor tissue perfusion. Severe hyperviscosity is a near-emergency that may require plasmapheresis to mechanically remove M-protein from the bloodstream while chemotherapy starts to work. Owners noticing sudden vision loss, neurologic decline, or unusual bleeding in a dog with confirmed or suspected myeloma should call the oncology team or emergency vet promptly.

Standard Treatment — Melphalan and Prednisone

The cornerstone treatment for canine multiple myeloma is the combination of melphalan (an oral alkylating chemotherapy agent) and prednisone for dogs. This combination is well-tolerated by most dogs, achieves meaningful response rates (most dogs experience reduction in M-protein, improvement in clinical signs, and partial or complete biochemical remission), and is administered orally at home, which simplifies logistics. Side effects of melphalan include bone marrow suppression (requiring CBC monitoring on each cycle) and rare GI signs; prednisone side effects include the familiar increased thirst, urination, and appetite. Bisphosphonates may be added for dogs with significant lytic bone disease or hypercalcemia.

Your oncology team will dose by weight, disease severity, and bloodwork response. Cycle frequency, dose adjustment, and monitoring schedule are individualized — this is not a protocol-card recipe. Most dogs see clinical improvement within the first one to two months, with biochemical response (declining M-protein on serum electrophoresis) tracked at regular rechecks.

Second-Line and Rescue Options

Dogs whose disease progresses on melphalan-prednisone or who relapse after initial response have several rescue options:

  • Cyclophosphamide — alternative alkylating agent, sometimes substituted for melphalan.
  • Lomustine (CCNU) — alkylating agent active in some lymphoid malignancies.
  • Doxorubicin — used in select rescue protocols.
  • Bortezomib — proteasome inhibitor used in human myeloma; veterinary use is more limited but reported in published cases.
  • Radiation therapy — useful for solitary bone lesions causing severe pain or risk of pathologic fracture.
  • Plasmapheresis — mechanical reduction of M-protein for hyperviscosity emergencies; available at select referral centers.

Rescue therapy is oncology-driven and individualized.

Supportive Care and Quality of Life

Beyond chemotherapy, supportive care addresses complications:

  • Pain control for bone lesions — gabapentin, NSAIDs cautiously (with kidney function monitoring), opioids for severe acute pain.
  • Antibiotics for secondary infections — myeloma dogs are functionally immunocompromised even before chemotherapy starts.
  • IV fluid therapy and supportive care for hypercalcemia.
  • Bisphosphonate therapy for bone disease.
  • ACE inhibitors and dietary management for myeloma-related kidney disease.
  • Activity modification — avoid jumping and rough play in dogs with significant spinal lytic lesions to reduce pathologic fracture risk.
  • Soft, comfortable bedding; ramps to favorite resting spots; floor-level food and water.

Prognosis

The published veterinary literature describes prognosis for canine multiple myeloma as fair to good with treatment — better than many other canine cancers and comparable to or slightly better than canine lymphoma in many series. Specific median survival times vary significantly across studies and across individual cases, and we will not invent a specific number here. What is honest is that many dogs achieve good biochemical and clinical response on melphalan-prednisone and live for a meaningful period of months to years with reasonable quality of life. Dogs with severe hypercalcemia at presentation, significant kidney disease, hyperviscosity syndrome, or extramedullary (non-bone) plasmacytoma carry a more guarded prognosis. Dogs whose disease responds well initially may eventually develop drug resistance and progress despite continued therapy.

This is one of the cancers where end-of-life conversations matter at presentation and again as the disease evolves. The ASPCA Pet Loss hotline at (877) 474-3310 is a free resource for owners weighing humane euthanasia decisions. Our pet loss support resources guide explains what is available.

Cost Realism and Insurance Timing

Canine multiple myeloma is an internal-medicine and oncology workup with substantial running costs. Initial diagnosis (bloodwork, electrophoresis, skeletal survey, bone marrow, ultrasound) easily reaches the thousands-of-dollars territory. Chemotherapy, recheck bloodwork every two to four weeks initially and every four to eight weeks once stable, electrophoresis at intervals, and supportive care add ongoing monthly costs. Pet insurance is most useful when purchased before any cancer diagnosis appears on the medical record; see our pet insurance decision for dogs overview. CareCredit and scratch funds are reasonable resources to know about. The veterinary specialist cost breakdown helps you plan oncology care financially.

Living With and Adopting a Myeloma Dog

Dogs in active myeloma treatment with stable response are typical, comfortable senior dogs with a chemotherapy schedule. They walk, eat, and enjoy life normally most of the time. Adoption of a dog with diagnosed multiple myeloma is uncommon but not unreasonable for households experienced with cancer care; the rescue should provide complete medical records, current treatment plan, and oncology recheck schedule, and the future vet should review everything before commitment. Many of these dogs become deeply bonded with caregivers during treatment and adopt beautifully where the household is prepared for the medical workload and is realistic about prognosis.

When to See Your Vet — and When to Ask for Oncology

Schedule a primary-vet visit for any older dog with vague illness, weight loss, increased thirst and urination, recurrent infections, or back or limb pain — and ask for total protein with globulin to be reviewed on the chemistry panel. Elevated globulin without a clear infectious or inflammatory cause warrants serum protein electrophoresis. Ask for an ACVIM-Oncology referral when myeloma is diagnosed or strongly suspected — this is one of the cancers where specialist-managed care produces meaningfully better outcomes. ACVIM-Internal Medicine handles the workup and complications in centers without dedicated oncology. The veterinary specialist cost breakdown helps you plan financially.

Frequently Asked Questions

Is multiple myeloma curable in dogs?

No, multiple myeloma is treatable but not curable in dogs. The realistic goal is durable remission and good quality of life on tolerable maintenance chemotherapy for as long as the response holds, often many months and sometimes years. Eventual progression and drug resistance are part of the disease’s natural history.

What is the difference between myeloma and lymphoma?

Both are cancers of white blood cells, but lymphoma arises from lymphocytes and primarily enlarges lymph nodes, while myeloma arises from plasma cells and primarily affects bone marrow and produces a monoclonal antibody spike. Treatment, monitoring, and prognosis differ. See our lymphoma guide for the lymphoma-side picture.

Can my dog still go on walks during chemotherapy?

Yes. Gentle leashed walks are encouraged and good for mood and overall function. Avoid rough play, jumping, and high-impact activity if your dog has significant lytic bone lesions, because pathologic fracture risk is real. Your oncology team will guide on activity modifications.

Will my dog feel sick on chemotherapy?

Most dogs tolerate melphalan-prednisone well and feel better, not worse, as treatment reduces myeloma burden and improves clinical signs. Mild GI upset and bone marrow effects are possible but are managed with anti-nausea medication and dose adjustments. Veterinary chemotherapy aims for quality of life, not human-style intensive treatment.

Should I consider euthanasia if my dog has multiple myeloma?

Most dogs are not candidates for immediate euthanasia at diagnosis — many have months to years of good quality life ahead with treatment. Euthanasia conversations become relevant when disease progresses despite rescue therapy, when complications (severe hyperviscosity, pathologic fractures, kidney failure) compromise quality of life, or when treatment becomes financially or logistically unsustainable. The ASPCA Pet Loss hotline at (877) 474-3310 is available throughout the journey for owners weighing decisions.

Ready to adopt?

Find your perfect companion from shelters and rescues near you.

Browse Adoptable Pets

Related articles

Why Does My Chinchilla Nibble Me?
Pet Care

Why Does My Chinchilla Nibble Me?

Wondering why does my chinchilla nibble me? Learn what gentle nibbling means, from grooming and affection to attention-seeking, and how to respond kindly.

Why Does My Chinchilla Rub His Chin?
Pet Care

Why Does My Chinchilla Rub His Chin?

Wondering why does my chinchilla rub his chin? Learn about scent marking, territory, and the rare dental signs that mean it is time to call an exotics vet.

Why Does My Chinchilla Cough?
Pet Care

Why Does My Chinchilla Cough?

Worried why does my chinchilla cough? Learn the dust, respiratory, and dental causes of coughing and exactly when to call an exotics vet right away.